TGM2 and cancer: According to cancer in PDAC and lung squamous cell carcinoma, TG2 expression has been identified as immunosuppressive and associated with a poor clinical outcome since increased numbers of M2 macrophages and regulatory T cells have been observed, along with reduced numbers of pro-B and memory B cells [148].